ArticleBiochemical pharmacology2018

HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.

Xuehai Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.